Deskripsi
Clinical trial dosing comparisons for EPA-only, DHA-only, and combined EPA+DHA supplementation protocols highlight the importance of distinguishing individual fatty acid effects.
Figure 14
Source Paper
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?Cite This Figure
![Figure 14: Clinical trial dosing comparisons for EPA-only, DHA-only, and combined EPA+DHA supplementation protocols highlight the importance of distinguishing individual fatty acid effects.]() > Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)
<figure> <img src="" alt="Clinical trial dosing comparisons for EPA-only, DHA-only, and combined EPA+DHA supplementation protocols highlight the importance of distinguishing individual fatty acid effects." /> <figcaption>Figure 14. Clinical trial dosing comparisons for EPA-only, DHA-only, and combined EPA+DHA supplementation protocols highlight the importance of distinguishing individual fatty acid effects.<br> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption> </figure>